Stockscreener 앱 받기
6.82
4.21%
-0.30
시간 외 거래:
6.66
-0.16
-2.35%
전일 마감가:
$7.12
열려 있는:
$7.2
하루 거래량:
88,062
Relative Volume:
0.81
시가총액:
$34.04M
수익:
$34.77M
순이익/손실:
$-74.04M
주가수익비율:
-0.8633
EPS:
-7.9
순현금흐름:
$-79.76M
1주 성능:
-6.83%
1개월 성능:
-3.12%
6개월 성능:
-46.76%
1년 성능:
-80.79%
1일 변동 폭
$6.7902
$7.25
1주일 범위
$6.7902
$7.55
52주 변동 폭
$5.21
$70.75
Mersana Therapeutics Inc Stock (MRSN) Company Profile
명칭
Mersana Therapeutics Inc
전화
617-498-0020
주소
840 MEMORIAL DRIVE, CAMBRIDGE
MRSN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRSN
Mersana Therapeutics Inc
|
6.82 | 35.53M | 34.77M | -74.04M | -79.76M | -7.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Mersana Therapeutics Inc Stock (MRSN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-06 | 개시 | William Blair | Outperform |
| 2024-11-15 | 재개 | Citigroup | Buy |
| 2024-03-19 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-29 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-02-29 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-02-29 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2023-12-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-28 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-07-27 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-07-27 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-07-27 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-07-27 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-07-27 | 다운그레이드 | Truist | Buy → Hold |
| 2023-07-27 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-06-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-06-15 | 개시 | Guggenheim | Buy |
| 2023-03-16 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-01-20 | 개시 | Citigroup | Buy |
| 2022-11-21 | 개시 | Truist | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-08-30 | 개시 | H.C. Wainwright | Buy |
| 2021-03-31 | 개시 | Credit Suisse | Neutral |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-09-29 | 재개 | JP Morgan | Neutral |
| 2020-04-29 | 개시 | BTIG Research | Buy |
| 2020-01-21 | 재확인 | H.C. Wainwright | Buy |
| 2019-03-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-11-14 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-05-08 | 개시 | Robert W. Baird | Outperform |
| 2018-03-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
모두보기
Mersana Therapeutics Inc 주식(MRSN)의 최신 뉴스
Mersana Therapeutics Faces Nasdaq Non-Compliance Notice - MSN
Can Mersana Therapeutics Inc. stock double in the next year2025 Institutional Moves & Daily Market Momentum Tracking - خودرو بانک
Can Mersana Therapeutics Inc. reach resistance levels soon2025 Price Action Summary & Verified Swing Trading Watchlists - خودرو بانک
Published on: 2025-09-05 14:49:22 - Newser
What does recent volatility data suggest for Mersana Therapeutics Inc.Trade Entry Summary & Fast Gain Stock Trading Tips - Newser
How sentiment analysis helps forecast Mersana Therapeutics Inc.2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Can Mersana Therapeutics Inc. deliver alphaJuly 2025 Sector Moves & Technical Buy Zone Confirmation - خودرو بانک
Key resistance and support levels for Mersana Therapeutics Inc.Quarterly Performance Summary & Daily Market Momentum Tracking - Newser
Using Bollinger Bands to evaluate Mersana Therapeutics Inc.Weekly Trade Summary & Real-Time Buy Signal Notifications - Newser
Published on: 2025-09-05 05:23:37 - Newser
What Fibonacci levels say about Mersana Therapeutics Inc. reboundJuly 2025 Breakouts & Weekly Setup with High ROI Potential - Newser
What data driven models say about Mersana Therapeutics Inc.’s futureAnalyst Downgrade & Safe Swing Trade Setup Alerts - Newser
Mersana Therapeutics Inc. recovery potential after sell offQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
Mersana Therapeutics’ Earnings Call Highlights Progress and Challenges - MSN
How sensitive is Mersana Therapeutics Inc. to inflation2025 Winners & Losers & AI Powered Trade Plan Recommendations - خودرو بانک
Is Mersana Therapeutics Inc. reversing from oversold territoryMarket Performance Report & Real-Time Market Sentiment Alerts - Newser
How volatile is Mersana Therapeutics Inc. stockWeekly Trade Report & Long Hold Capital Preservation Tips - خودرو بانک
Will Mersana Therapeutics Inc. face regulatory challengesJuly 2025 Drop Watch & Reliable Breakout Stock Forecasts - khodrobank.com
Is Mersana Therapeutics Inc. stock reversal real or fake2025 EndofYear Setup & Risk Managed Investment Signals - Newser
Will Mersana Therapeutics Inc. outperform the marketStop Loss & High Accuracy Swing Entry Alerts - Newser
Is Mersana Therapeutics Inc. a top pick in the sectorDividend Hike & Weekly Market Pulse Updates - خودرو بانک
Has Mersana Therapeutics Inc. formed a bullish divergenceMarket Risk Summary & Proven Capital Preservation Methods - Newser
Best data tools to analyze Mersana Therapeutics Inc. stockMarket Volume Summary & Low Risk Entry Point Guides - Newser
Evaluating Mersana Therapeutics Inc. with trendline analysisRisk Management & Risk Managed Trade Strategies - Newser
Leading vs lagging indicators on Mersana Therapeutics Inc. performanceJuly 2025 Analyst Calls & Weekly High Momentum Picks - Newser
Analyzing net buyer seller activity in Mersana Therapeutics Inc.July 2025 Technicals & Verified Momentum Stock Alerts - Newser
What recovery options are there for Mersana Therapeutics Inc.2025 Technical Overview & Verified Trade Idea Suggestions - Newser
Will Mersana Therapeutics Inc. bounce back from current support2025 Technical Overview & Accurate Intraday Trade Tips - Newser
How moving averages guide Mersana Therapeutics Inc. tradingWeekly Stock Report & Risk Controlled Swing Alerts - Newser
Using Python tools to backtest Mersana Therapeutics Inc. strategiesAnalyst Upgrade & Weekly Return Optimization Plans - Newser
Using data tools to time your Mersana Therapeutics Inc. exitEarnings Growth Report & Entry Point Confirmation Alerts - Newser
Can Mersana Therapeutics Inc. generate free cash flowJuly 2025 Summary & Consistent Return Strategy Ideas - خودرو بانک
Sector ETF performance correlation with Mersana Therapeutics Inc.Options Play & High Win Rate Trade Tips - Newser
Can momentum traders help lift Mersana Therapeutics Inc.2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - Newser
Ranking Mersana Therapeutics Inc. among high performing stocks via toolsWeekly Trend Report & Weekly Setup with ROI Potential - Newser
Chart based exit strategy for Mersana Therapeutics Inc.2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Is Mersana Therapeutics Inc. stock forming a cup and handleJuly 2025 Technicals & Reliable Entry Point Alerts - خودرو بانک
Is now a turning point for Mersana Therapeutics Inc.Trade Exit Summary & High Return Trade Opportunity Guides - Newser
Mersana Therapeutics Inc (MRSN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):